Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
Files Investor Presentation and Issues Open Letter to Stockholders Urges Stockholders to Protect the Value of Their Investment by Voting...
Morning Movers
HomesToLife Ltd Announces Closing of Acquisition of HTL Marketing Pte Ltd
Singapore, May 19, 2025 (GLOBE NEWSWIRE) -- HomesToLife Ltd (NASDAQ: HTLM) (“HomesToLife” or the “Company”), the holding company of one...
Eshallgo Inc Announces Establishment of U.S. Subsidiary to Support Long-Term Global Growth Strategy
SHANGHAI, May 19, 2025 /PRNewswire/ -- Eshallgo Inc ("Eshallgo" or the "Company") (NasdaqCM: EHGO), a Chinese well-established office integrator and...
aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis largely balanced and...
Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies
HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T...
Astera Labs Expands Collaboration with NVIDIA to Advance NVLink Fusion Ecosystem
SANTA CLARA, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity...
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
ROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
180 Degree Capital Corp. Issues Q1 2025 Shareholder Letter
MONTCLAIR, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) today issued the following Q1 2025 Shareholder...
Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000
TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the...
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as...
PERMIAN BASIN ROYALTY TRUST ANNOUNCES MAY CASH DISTRIBUTION AND EXCESS COST POSITION ON WADDELL RANCH PROPERTIES
DALLAS, May 19, 2025 /PRNewswire/ -- Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian" or...
Patrick Industries Welcomes Back Jake Petkovich as President – Marine; Rick Reyenger Transitions to Strategic Advisory Role
ELKHART, Ind., May 19, 2025 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ: PATK) ("Patrick" or the "Company"), a leading component solutions...
Blackbaud Named One of Newsweek’s World’s Greenest Companies 2025
Award Evaluates Global Sustainability Practices, ESG Performance Data and Key Environmental Metrics CHARLESTON, S.C., May 19, 2025 /PRNewswire/ -- Blackbaud (NASDAQ:...
aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis largely balanced and...
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based...
Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 19,...
ManpowerGroup Announces Investment in New Paris-Based AI HR Hub at Choose France Summit
PARIS, May 19, 2025 /PRNewswire/ -- ManpowerGroup (NYSE: MAN), global leader in innovative workforce solutions, announces the launch of its new AI...
Kimberly-Clark to Transfer U.S. Stock Exchange Listing to Nasdaq
Ticker symbol to remain "KMB" DALLAS, May 19, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB), a global leader in the...
Workday Unveils Next Generation of Illuminate Agents to Transform HR and Finance Operations
New AI Agents Help Speed Hiring, Improve Frontline Worker Experiences, Streamline Complex Financial Processes, and Empower Employees to Find Information...
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced...
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move...
Tecnoglass to Attend the B. Riley Securities 25th Annual Institutional Investor Conference
Miami, FL, May 19, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end...
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
$3 billion in cash and stock, inclusive of a contingent payment of up to $450 millionAMD retains ZT Systems’ rack-scale...
XORTX Announces USD $3 Million Offering
CALGARY, Alberta, May 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma
SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first...
Plug Power CFO, Paul Middleton, Underscores Confidence in Financial Strength and Strategic Growth with Share Purchase
SLINGERLANDS, N.Y., May 19, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive solutions for...
BTCS Inc. to Participate in Fireside Chat at Benchmark Digital Assets Virtual Seminar
Silver Spring, Maryland--(Newsfile Corp. - May 19, 2025) - BTCS Inc. (NASDAQ: BTCS) ("BTCS" or the "Company"), a blockchain technology-focused...
TopBuild Extends and Upsizes Senior Secured Credit Facilities
DAYTONA BEACH, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE: BLD), a leading installer and specialty distributor of...
Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 19,...
Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
Topline data expected by year endHead-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons...
Microvast at CIBF 2025: Powering What’s Next
STAFFORD, Texas, May 19, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast" or the "Company"), a global leader in...
CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma
SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
The Alkaline Water Company Announces Midwest Expansion with Products Now Available at Woodman’s Markets
GLENDALE, Ariz., May 19, 2025 /PRNewswire/ -- The Alkaline Water Company, Inc. (OTC: WTER -- hereinafter referred to as the...
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats
Clinical Paper Published in BMC Veterinary Research HENDERSON, Nev., May 19, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"),...
Global Ship Lease Reports Results for the First Quarter of 2025
Forward contract cover locked in for 93% of 2025 days and 75% of 2026 days Annualized dividend increased to $2.10...
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”)...
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”)...
TransDigm Group and Servotronics, Inc. Announce Acquisition Agreement
CLEVELAND and ELMA, N.Y., May 19, 2025 /PRNewswire/ -- TransDigm Group Incorporated ("TransDigm") (NYSE: TDG) and Servotronics, Inc. ("Servotronics") (NYSE...